Find stats on top websites
Major Markets
Key Competitors
RxFunction positions Walkasins as a leading, prescription-only medical device that restores balance and reduces fall risk for individuals with sensory peripheral neuropathy, emphasizing its clinically supported efficacy and role as a sensory prosthesis.
Customer sentiment is likely positive among healthcare professionals due to the device's clinical evidence and patient outcome focus, while patients would appreciate improved mobility and reduced fall anxiety, despite potential initial cost concerns. The value proposition of independence and safety resonates strongly with both prescribers and end-users.
The key value proposition is Walkasins' ability to significantly reduce fall risk and improve walking balance for individuals with sensory peripheral neuropathy. It achieves this by replacing lost foot pressure sensation, thereby enhancing mobility and confidence in daily life.
Specialized medical device for neuropathy.
Addresses critical fall prevention need.
Clinically supported and prescription-based.
Limited product portfolio (single product).
Reliance on physician prescriptions.
Potential high cost for patients/insurers.
Expanding prevalence of neuropathy.
Partnerships with healthcare networks.
New applications for sensory prosthetics.
Competitive medical device market.
Insurance reimbursement challenges.
Regulatory hurdles and approvals.
Primarily focused on the US market due to federal regulations. Limited international presence currently, with small shares in Canada, UK, Germany, and Australia.
United States
90% market share
Canada
3% market share
United Kingdom
2% market share
Germany
1.5% market share
Australia
1% market share
30-65 years
Male • Female
USA
45-70 years
Male • Female
USA
60-90 years
Male • Female
USA
40-70 years
Male • Female
USA
25-55 years
Male • Female
USA
Data shown in percentage (%) of usage across platforms
Create an interactive ROI calculator on the Walkasins website. This tool will allow healthcare professionals to input patient data and estimate the potential return on investment from reduced fall-related costs and improved patient outcomes, showcasing the device's economic value.
Learn moreDevelop a comprehensive buyer's guide for healthcare providers focusing on Walkasins. This guide would detail the device's clinical efficacy, patient suitability criteria, implementation protocols, and reimbursement information, empowering informed decisions and driving adoption.
Learn moreEncourage and showcase testimonials and success stories from both healthcare professionals and patients using Walkasins. This will build trust and credibility by highlighting real-world results and demonstrating the positive impact of the device on patient lives.
Learn moreSign up now and unleash the power of AI for your business growth